Get the Stockscreener App
57.08
1.16%
-0.67
Conmed Corp stock is traded at $57.08, with a volume of 285.81K.
It is down -1.16% in the last 24 hours and up +0.53% over the past month.
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Geographically operates in USA, Europe, Middle East & Africa, Asia Pacific and North America. Majority is revenue is from USA.
See More
Previous Close:
$57.75
Open:
$57.78
24h Volume:
285.81K
Relative Volume:
0.54
Market Cap:
$1.78B
Revenue:
$1.29B
Net Income/Loss:
$131.74M
P/E Ratio:
13.56
EPS:
4.21
Net Cash Flow:
$166.13M
1W Performance:
-1.04%
1M Performance:
+0.53%
6M Performance:
-22.27%
1Y Performance:
-18.85%
1-Day Range:
$56.80
$58.42
1-Week Range:
$54.83
$58.58
52-Week Range:
$46.00
$78.58
Conmed Corp Stock (CNMD) Company Profile
Name
Conmed Corp
Sector
Industry
Phone
727-214-2974
Address
11311 CONCEPT BOULEVARD, LARGO, NY
Compare CNMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CNMD
Conmed Corp
|
57.08 | 1.78B | 1.29B | 131.74M | 166.13M | 4.21 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Conmed Corp Stock (CNMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-28-25 | Downgrade | Stifel | Buy → Hold |
| Feb-06-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-01-24 | Reiterated | Needham | Buy |
| May-22-23 | Initiated | CL King | Buy |
| Mar-27-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-21-23 | Initiated | Wells Fargo | Equal Weight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Oct-06-21 | Upgrade | Needham | Hold → Buy |
| Jul-15-21 | Initiated | UBS | Buy |
| May-25-21 | Initiated | Barclays | Overweight |
| Nov-26-19 | Downgrade | Needham | Buy → Hold |
| Nov-12-19 | Initiated | JP Morgan | Overweight |
| Oct-31-19 | Reiterated | Needham | Buy |
| Oct-04-19 | Reiterated | Needham | Buy |
| Aug-22-19 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Apr-18-19 | Initiated | Stifel | Buy |
| Apr-16-19 | Reiterated | Needham | Buy |
| Jan-23-19 | Reiterated | Needham | Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Aug-07-18 | Reiterated | Needham | Buy |
| Aug-02-18 | Reiterated | Needham | Buy |
| Apr-26-18 | Reiterated | Needham | Buy |
| Feb-01-18 | Reiterated | Needham | Buy |
| Jul-27-17 | Reiterated | Needham | Buy |
| Apr-27-17 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Apr-27-17 | Reiterated | Needham | Buy |
| Nov-18-16 | Reiterated | Needham | Buy |
| Jul-28-16 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| Apr-28-16 | Reiterated | Needham | Buy |
| Oct-22-15 | Reiterated | Northland Capital | Market Perform |
View All
Conmed Corp Stock (CNMD) Latest News
CONMED Co. (NYSE:CNMD) Shares Acquired by Dean Capital Management - MarketBeat
CONMED (NYSE:CNMD) Rating Lowered to “Hold” at StockNews.com - Defense World
ArrowMark Colorado Holdings LLC Decreases Position in CONMED Co. (NYSE:CNMD) - MarketBeat
CONMED Co. (NYSE:CNMD) Stock Holdings Raised by First Trust Advisors LP - Defense World
Dimensional Fund Advisors LP Has $53.07 Million Stock Position in CONMED Co. (NYSE:CNMD) - MarketBeat
Insider Selling: Charles Farkas Sells 4,000 Shares of Conmed Cor - GuruFocus
PDT Partners LLC Sells 13,579 Shares of CONMED Co. (NYSE:CNMD) - MarketBeat
CONMED Co. (NYSE:CNMD) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Decoding Conmed Corp (CNMD): A Strategic SWOT Insight - GuruFocus
CONMED (NYSE:CNMD) Issues Earnings Results - MarketBeat
CONMED (NYSE:CNMD) Given New $61.00 Price Target at Needham & Company LLC - MarketBeat
JPMorgan Chase & Co. Issues Pessimistic Forecast for CONMED (NYSE:CNMD) Stock Price - Defense World
Earnest Partners LLC Acquires 25,876 Shares of CONMED Co. (NYSE:CNMD) - MarketBeat
CONMED (NYSE:CNMD) Stock Rating Lowered by Stifel Nicolaus - MarketBeat
CONMED (NYSE:CNMD) Shares Gap Up Following Better-Than-Expected Earnings - Defense World
CNMD’s 52-Week Rollercoaster: From $46.00 to $78.58 – What’s Next for Investors? - investchronicle.com
Why Conmed (CNMD) is a Top Value Stock for the Long-Term - Yahoo Finance
CONMED Corporation (NYSE:CNMD) Q1 2025 Earnings Call Transcript - Insider Monkey
Conmed (CNMD) Target Price Lowered by Wells Fargo Analyst | CNMD Stock News - GuruFocus
JP Morgan Revises Price Target for Conmed (CNMD) to $58 | CNMD S - GuruFocus
Conmed Corp (CNMD) can make a big difference with a little luck - Sete News
Conmed (CNMD) Analyst Rating Update: Price Target Lowered | CNMD Stock News - GuruFocus
CONMED Corp SEC 10-Q Report - TradingView
Conmed (CNMD) Target Price Adjusted by Analyst Amid Supply Chain - GuruFocus
Conmed (CNMD) Target Price Adjusted by Analyst Amid Supply Chain Challenges | CNMD Stock News - GuruFocus
CNMD Stock Up On Q1 Earnings & Sales Beat, Raised 2025 Outlook - Yahoo Finance
Breaking Down Conmed: 6 Analysts Share Their Views - Benzinga
Conmed (CNMD) Target Price Reduced by Wells Fargo Analyst | CNMD Stock News - GuruFocus
CONMED (CNMD) Reports Strong Q1 Revenue Surpassing Estimates | C - GuruFocus
Conmed: Q1 Earnings Snapshot - MySA
Conmed Corp [CNMD] Insider Activity: An Update for Investors - knoxdaily.com
Conmed Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Earnings call transcript: ConMed’s Q1 2025 earnings miss EPS forecasts, stock rises - Investing.com
CONMED beats Q1 revenue estimates, raises full-year outlook; shares jump By Investing.com - Investing.com South Africa
CONMED beats Q1 revenue estimates, raises full-year outlook; shares jump - Investing.com Canada
CONMED Q1 2025 slides: Revenue growth continues amid GAAP earnings pressure - Investing.com Canada
CONMED Corporation Announces First Quarter 2025 Financial Results - Stock Titan
CONMED (NYSE:CNMD) Downgraded by Stifel Nicolaus to “Hold” - Defense World
CONMED (CNMD) Downgraded by Stifel Due to Sales Decline - GuruFocus
What To Expect From CONMED’s (CNMD) Q1 Earnings - Barchart.com
Orthopedic Biomaterial Market Overall Study Report 2025-2032 | - openPR.com
Conmed stock rating cut to hold at Stifel, target drops to $55 - Investing.com Canada
Conmed stock rating cut to hold at Stifel, target drops to $55 By Investing.com - Investing.com South Africa
Conmed (CNMD) Downgraded by Stifel Amid Economic Concerns | CNMD Stock News - GuruFocus
CONMED (NYSE:CNMD) Sets New 1-Year LowWhat's Next? - MarketBeat
Natixis Has $7.80 Million Stock Holdings in CONMED Co. (NYSE:CNMD) - MarketBeat
Fuller & Thaler Asset Management Inc. Takes $59.05 Million Position in CONMED Co. (NYSE:CNMD) - MarketBeat
Barclays PLC Trims Holdings in CONMED Co. (NYSE:CNMD) - MarketBeat
CONMED Co. (NYSE:CNMD) Shares Purchased by Capital Research Global Investors - MarketBeat
Raymond James Financial Inc. Purchases New Position in CONMED Co. (NYSE:CNMD) - MarketBeat
CONMED (CNMD) Expected to Announce Earnings on Wednesday - MarketBeat
Conmed Corp Stock (CNMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):